Evidence map›Paper›PMID 25257373›Full record

ArticleMicrobiologyOpen2014

Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants.

Allister J Loughran, Danielle N Atwood, Allison C Anthony, Nada S Harik, Horace J Spencer, Karen E Beenken, Mark S Smeltzer

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 89 citations in OpenAlex.

  1. Prevention and Treatment ofPathogens (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Microorganisms · 2025
    Review
  4. Article
  5. The ability ofInfection and immunity · 2025
    Article
  6. Article
  7. Structural characteristics, functions, and counteracting strategies of biofilms inComputational and structural biotechnology journal · 2025
    Review
  8. Pathogens (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Sub-inhibitory concentrations of ceftriaxone induce morphological alterations and PIA-independent biofilm formation in Staphylococcus aureus.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  14. Article
  15. Article
  16. Natural compounds in the fight againstFrontiers in pharmacology · 2024
    Review
  17. Review
  18. Drug delivery strategies for antibiofilm therapy.Nature reviews. Microbiology · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Allister J LoughranDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Danielle N Atwood
Allison C Anthony
Nada S Harik
Horace J Spencer
Karen E Beenken
Mark S Smeltzer
University of Arkansas for Medical Sciences · USArkansas Children's Hospital · US

Funding

Study of the Cell-specific Inflammasome Responses During Defense Against Gram-negative BacteriaP20GM103625 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2012 to 2021
$21.5M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Impact of Staphylococcus aureus in osteomyelitis and bone physiologyR01AI119380 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI BEENKEN, KAREN E., SMELTZER, MARK S · 2015 to 2025
$4.1M
Center for Protein Structure and FunctionP30GM103450 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2012 to 2014
$3.2M
Regulation of biofilm formation in clinical isolates of Staphylococcus aureusR01AI074935 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2007 to 2011
$1.6M
A nanotherapeutic approach to combat staphylococcal biofilm-associated infectionR56AI093126 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2011 to 2011
$360k
Regulation of biofilm formation in clinical isolates of Staphylococcus aureusR56AI074935 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2013 to 2013
$341k
NCATS NIH HHS UL1 TR000039NIAID NIH HHS R01 AI074935NIAID NIH HHS R01 AI119380NIAID NIH HHS R56 AI074935NIAID NIH HHS R56 AI093126NIGMS NIH HHS P20-GM103450NIGMS NIH HHS P20 GM103625NIGMS NIH HHS P30 GM103450
6 · The paper itself

Abstract

We demonstrate that the purified Staphylococcus aureus extracellular proteases aureolysin, ScpA, SspA, and SspB limit biofilm formation, with aureolysin having the greatest impact. Using protease-deficient derivatives of LAC, we confirmed that this is due to the individual proteases themselves. Purified aureolysin, and to a lesser extent ScpA and SspB, also promoted dispersal of an established biofilm. Mutation of the genes encoding these proteases also only partially restored biofilm formation in an FPR3757 sarA mutant and had little impact on restoring virulence in a murine bacteremia model. In contrast, eliminating the production of all of these proteases fully restored both biofilm formation and virulence in a sarA mutant generated in the closely related USA300 strain LAC. These results confirm an important role for multiple extracellular proteases in S. aureus pathogenesis and the importance of sarA in repressing their production. Moreover, purified aureolysin limited biofilm formation in 14 of 15 methicillin-resistant isolates and 11 of 15 methicillin-susceptible isolates, while dispersin B had little impact in UAMS-1, LAC, or 29 of 30 contemporary isolates of S. aureus. This suggests that the role of sarA and its impact on protease production is important in diverse strains of S. aureus irrespective of their methicillin resistance status.

Indexed as

BiofilmsAnimalsBacterial ProteinsCysteine EndopeptidasesFemaleHumansMiceMutationSerine EndopeptidasesStaphylococcal InfectionsStaphylococcus aureusTrans-ActivatorsVirulenceBacterial ProteinsCysteine Endopeptidasesglutamyl endopeptidaseSarA protein, bacterialSerine EndopeptidasessspB protein, Staphylococcus aureusstaphopain A protein, Staphylococcus aureusTrans-ActivatorsBiofilmproteasessarAStaphylococcus aureus

Identifiers

PMID25257373
PMCPMC4263513
OpenAlexW1987294201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.